Evaluation of three commercial serological tests with different methodologies to assess Helicobacter pylori infection

The sera of 142 Helicobacter pylori-positive and 32 H. pylori-negative patients were assessed by a desktop test (QuickVue), an enzyme-linked immunosorbent assay (ELISA) (HM-CAP), and a solid-phase, two-step chemiluminescent enzyme immunoassay (Immulite). These tests yielded sensitivities of 97, 97,...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical microbiology Vol. 37; no. 12; pp. 4150 - 4152
Main Authors VAN DER ENDE, A, VAN DER HULST, R. W. M, ROORDA, P, TYTGAT, G. N. J, DANKERT, J
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.12.1999
SeriesNote
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The sera of 142 Helicobacter pylori-positive and 32 H. pylori-negative patients were assessed by a desktop test (QuickVue), an enzyme-linked immunosorbent assay (ELISA) (HM-CAP), and a solid-phase, two-step chemiluminescent enzyme immunoassay (Immulite). These tests yielded sensitivities of 97, 97, and 91% and specificities of 97, 94, and 100%, respectively. In conclusion, the desktop test and the ELISA are more sensitive than the chemiluminescent enzyme immunoassay (P < 0.05). The chemiluminescent enzyme immunoassay has the advantage that it is fully automated.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Present address: Kennemer Gasthuis, Department of Internal Medicine, Gastroenterology, 2023 EA Haarlem, The Netherlands.
Corresponding author. Mailing address: Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. Phone: 31-20-5664862. Fax: 31-20-6979271.
ISSN:0095-1137
1098-660X
DOI:10.1128/JCM.37.12.4150-4152.1999